Literature DB >> 22445222

Long-term results of artificial urinary sphincter for women with type III stress urinary incontinence.

Pierre Costa1, Gregoire Poinas, Kamel Ben Naoum, Khalid Bouzoubaa, Laurent Wagner, Laurent Soustelle, Michel Boukaram, Stéphane Droupy.   

Abstract

BACKGROUND: The use of the artificial urinary sphincter (AUS) in women is limited.
OBJECTIVE: To analyse long-term results and mechanical survival of the AUS (AMS 800; American Medical Systems, Minnetonka, MN, USA) in women with stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD). DESIGN, SETTING, AND PARTICIPANTS: Women with SUI who were treated between January 1987 and March 2007 were included in this prospective study. Only women with low closure pressure at urethral profile and negative continence tests, indicators of severe ISD, were included.
INTERVENTIONS: An AUS was implanted. The surgical technique was modified in 1999, involving opening the endopelvic fascia on both sides and dissection in contact with the vaginal wall. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Assessment of complications was made pre- and postoperatively and continence status was based on pad usage. Kaplan-Meier survival curves were used to calculate mechanical survival of the device. Student t test and the chi-square test were used to compare continence and complication rates. RESULTS AND LIMITATIONS: A total of 376 AUS were implanted in 344 patients, whose mean age was 57 yr. The mean follow-up, plus or minus standard deviation, was 9.6±4.0 yr. At last follow-up, postoperative continence rates, assessed as fully continent (no leakage), socially incontinent (some drops but no pad), or incontinent (one pad or more), were 85.6%, 8.8%, and 5.6%, respectively. The 3-, 5-, and 10-yr device survival rates were 92.0%, 88.6%, and 69.2%, respectively. The mean mechanical survival was 176 mo (14.7 yr). Three risk factors for AUS survival were the number of previous incontinence surgeries, the presence of neurogenic bladder, and simultaneous augmentation enterocystoplasty. Principal limitation of the study is the absence of validated incontinence questionnaire.
CONCLUSIONS: The AUS provides excellent outcome in women with ISD, with low explantation rate and very good device survival.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 22445222     DOI: 10.1016/j.eururo.2012.03.008

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  22 in total

Review 1.  Considerations in the modern management of stress urinary incontinence resulting from intrinsic sphincter deficiency.

Authors:  Christopher James Hillary; Nadir Osman; Christopher Chapple
Journal:  World J Urol       Date:  2015-06-10       Impact factor: 4.226

Review 2.  Treatment options for intrinsic sphincter deficiency.

Authors:  Sovrin M Shah; Geoffrey S Gaunay
Journal:  Nat Rev Urol       Date:  2012-10-02       Impact factor: 14.432

Review 3.  Management of failed stress urinary incontinence surgery.

Authors:  Lara S MacLachlan; Eric S Rovner
Journal:  Curr Urol Rep       Date:  2014-08       Impact factor: 3.092

4.  Artificial urinary sphincter implantation in women with stress urinary incontinence: preliminary comparison of robot-assisted and open approaches.

Authors:  Benoit Peyronnet; Sébastien Vincendeau; Lauranne Tondut; Karim Bensalah; Mireille Damphousse; Andréa Manunta
Journal:  Int Urogynecol J       Date:  2015-10-02       Impact factor: 2.894

Review 5.  [Artificial urinary sphincter in women-too uncommon?]

Authors:  H Sperling; A Kaufmann; I Bonn; M Zaum
Journal:  Urologe A       Date:  2017-12       Impact factor: 0.639

6.  Joint report on the terminology for surgical procedures to treat stress urinary incontinence in women.

Authors: 
Journal:  Int Urogynecol J       Date:  2020-03       Impact factor: 2.894

7.  Outcomes of artificial urinary sphincter in female with neurological stress urinary incontinence: a long-term follow-up.

Authors:  Thibault Tricard; A Schirmann; P Munier; A Schroeder; C Saussine
Journal:  World J Urol       Date:  2020-02-12       Impact factor: 4.226

8.  Functional outcomes of adjustable continence therapy (ACT™) balloons in women aged >80 years and suffering from stress urinary incontinence caused by intrinsic sphincter deficiency.

Authors:  Claire Billault; Emmanuel Chartier-Kastler; Morgan Rouprêt; Gilberte Robain; Véronique Phé
Journal:  World J Urol       Date:  2015-02-21       Impact factor: 4.226

Review 9.  Outcome measures for stress urinary incontinence treatment: can we minimally agree?

Authors:  Véronique Phé; Philippe Zimmern; Emmanuel Chartier-Kastler
Journal:  World J Urol       Date:  2015-03-20       Impact factor: 4.226

10.  [Therapy of persistent or recurrent stress urinary incontinence].

Authors:  A Soave; O Engel; M Rink; M Fisch; R Dahlem
Journal:  Urologe A       Date:  2014-03       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.